Differentiated human alveolar epithelial cells and reversibility of their phenotype in vitro.
about
Use of ex vivo and in vitro cultures of the human respiratory tract to study the tropism and host responses of highly pathogenic avian influenza A (H5N1) and other influenza virusesIn vitro model alveoli from photodegradable microsphere templates.Differentiated human alveolar type II cells secrete antiviral IL-29 (IFN-lambda 1) in response to influenza A infectionLong-chain acyl-CoA dehydrogenase deficiency as a cause of pulmonary surfactant dysfunctionVirus-infected alveolar epithelial cells direct neutrophil chemotaxis and inhibit their apoptosisRoflumilast-N-oxide induces surfactant protein expression in human alveolar epithelial cells type IIHistopathological evaluation of the diversity of cells susceptible to H5N1 virulent avian influenza virusDifferential Susceptibilities of Human Lung Primary Cells to H1N1 Influenza VirusesInnate immune response to influenza A virus in differentiated human alveolar type II cellsIn situ molecular identification of the influenza A (H1N1) 2009 Neuraminidase in patients with severe and fatal infections during a pandemic in Mexico CityAsparagine substitution at PB2 residue 701 enhances the replication, pathogenicity, and transmission of the 2009 pandemic H1N1 influenza A virus.Stem cells and cell therapies in lung biology and lung diseasesEpithelial Gpr116 regulates pulmonary alveolar homeostasis via Gq/11 signaling.Whole-genome analysis of temporal gene expression during early transdifferentiation of human lung alveolar epithelial type 2 cells in vitroDAS181 inhibits H5N1 influenza virus infection of human lung tissues.Lung fibroblasts accelerate wound closure in human alveolar epithelial cells through hepatocyte growth factor/c-Met signaling.Regulated gene expression in cultured type II cells of adult human lungTemporal changes in expression of FoxA1 and Wnt7A in isolated adult human alveolar epithelial cells enhanced by heparinHuman alveolar epithelial cell injury induced by cigarette smokeBioinformatics-driven discovery of rational combination for overcoming EGFR-mutant lung cancer resistance to EGFR therapy.Apoptosis induced by ozone and oxysterols in human alveolar epithelial cells.Knockdown of Drosha in human alveolar type II cells alters expression of SP-A in culture: a pilot study.The effect of interleukin-13 (IL-13) and interferon-γ (IFN-γ) on expression of surfactant proteins in adult human alveolar type II cells in vitroStem cells and cell therapy approaches in lung biology and diseases.Lung regeneration: mechanisms, applications and emerging stem cell populationsNeuregulin-1-human epidermal receptor-2 signaling is a central regulator of pulmonary epithelial permeability and acute lung injury.HMGB1 accelerates alveolar epithelial repair via an IL-1β- and αvβ6 integrin-dependent activation of TGF-β1Integrated transcriptomic and epigenomic analysis of primary human lung epithelial cell differentiation.Human coronavirus HKU1 infection of primary human type II alveolar epithelial cells: cytopathic effects and innate immune response.Lineage-negative progenitors mobilize to regenerate lung epithelium after major injuryIsolation of alveolar epithelial type II progenitor cells from adult human lungs.Viral replication and innate host responses in primary human alveolar epithelial cells and alveolar macrophages infected with influenza H5N1 and H1N1 virusesHER2 activation results in β-catenin-dependent changes in pulmonary epithelial permeabilityInfluenza induces IL-8 and GM-CSF secretion by human alveolar epithelial cells through HGF/c-Met and TGF-α/EGFR signalingHypoxia-inducible factor regulates expression of surfactant protein in alveolar type II cells in vitro.Normal Human Lung Epithelial Cells Inhibit Transforming Growth Factor-β Induced Myofibroblast Differentiation via Prostaglandin E2Enhanced proliferation of primary rat type II pneumocytes by Jaagsiekte sheep retrovirus envelope protein.Infection of human alveolar macrophages by human coronavirus strain 229E.Impaired pulmonary defense against Pseudomonas aeruginosa in VEGF gene inactivated mouse lung.Bacillus anthracis lethal toxin reduces human alveolar epithelial barrier function.
P2860
Q26859435-2415C2E8-6713-4C19-AAF5-E455187640DBQ27334956-9B579055-FF26-48E1-8490-F14D71192171Q28307217-BD98D6B1-3761-4542-B63A-CBC2516E1F29Q28308215-5477ACA5-A284-436F-90FA-0B96E95E4B05Q28575244-DA552F46-D197-42A8-8047-99EC41D2C664Q28729156-44C8EFC0-E983-4EB2-8733-59F024455F1DQ30355327-9D09367D-22A7-4665-9A1B-543D6E446038Q30379218-236EDBB8-777D-4C92-A196-ECFB6D3E8D71Q30398629-2B097D79-57E4-47C1-B7A6-A59F39C4E3AAQ30426042-A2B32E62-A05B-4C7E-8357-6FD20DAAD4C0Q30432390-8885C995-F545-4C53-81A5-CECF7633C40EQ30486086-73F39968-6C8C-4C4A-BF79-7AF423ADB6BDQ30854338-10DCBA29-7E55-40C8-AE8F-916C24CC559CQ31155165-48E1D641-C08F-4A53-A68E-9E8A81FB888CQ33481566-BCF1D32E-308E-4FC7-B252-EC98DC950621Q33840378-4606706C-4CB0-4945-A648-373864BFF2F6Q33994671-98F2F758-D76F-4D7D-BBEC-AB5550FD1CF9Q34046065-12E9E53E-0F47-4125-92D4-F6EA67D688A2Q34098078-70CCD9DA-31EC-4E11-BDCB-5C87D98E2153Q34103108-92F52422-8EE6-4647-BC86-97EC92590EB3Q34248712-77023569-40A3-4165-AD82-D9BBFF9AAFD6Q34339379-3CE7100D-EC19-4252-BEDF-4B08E44044B3Q34353603-9C777B2E-6C26-46AF-8CFC-0759E0CA8D8BQ34361245-A79E7BCC-F121-4BBF-9A2D-B48AA0E3F39FQ34497079-1FF61FF0-382D-4CE2-A615-66FEE9C3D2D0Q34695953-2DC1C481-090A-48CC-978C-6C4E0278E81DQ34734005-D41D156A-B014-4891-B8D1-C62C265A39B1Q34789360-2D8B2E33-2B5E-47AB-8689-DF8CABD98C9DQ34875544-C4E4DE46-64E0-40CE-98F2-F36A8047B6D9Q35032592-1DCD2E8C-D991-4CC4-83DF-D2CCE3C9FCE0Q35073643-59612C01-EE73-4CCB-8B87-755F3427FED7Q35077673-C9A09A36-7D7F-4D2F-ADF2-D77E5822D2C5Q35115872-389BAF31-FCF5-4E94-A4C1-8634D2A25915Q35672037-CB8A2482-7437-4E8C-9B8E-B560F85CADABQ35684878-E5F60DBB-AE39-4E5B-926E-C6BE51C657CFQ35738996-A710E2F8-274E-4DE8-B4BC-450028AD231AQ35810555-222B03B5-50F5-461D-A103-CC0D7CEF2A0CQ35960543-B2568258-7B77-4FA5-98E6-1CF8B35DD6CBQ36357042-613C2A43-C06C-4130-BD53-2019F0AA0048Q36396810-4749E4B8-C7B2-44F0-AA67-F4E018770CCC
P2860
Differentiated human alveolar epithelial cells and reversibility of their phenotype in vitro.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Differentiated human alveolar ...... y of their phenotype in vitro.
@ast
Differentiated human alveolar ...... y of their phenotype in vitro.
@en
type
label
Differentiated human alveolar ...... y of their phenotype in vitro.
@ast
Differentiated human alveolar ...... y of their phenotype in vitro.
@en
prefLabel
Differentiated human alveolar ...... y of their phenotype in vitro.
@ast
Differentiated human alveolar ...... y of their phenotype in vitro.
@en
P2093
P2860
P356
P1476
Differentiated human alveolar ...... y of their phenotype in vitro.
@en
P2093
C Joel Funk
Gregory P Cosgrove
Jieru Wang
Karen Edeen
Rizwan Manzer
Robert J Mason
Shuanglin Wang
Xiaohui Fang
Xueni Chen
Yongsheng Chang
P2860
P304
P356
10.1165/RCMB.2006-0410OC
P577
2007-01-25T00:00:00Z